HomeInsightsStock Comparison

Kilitch Drugs India Ltd vs Kimia Biosciences Ltd Stock Comparison

Kilitch Drugs India Ltd vs Kimia Biosciences Ltd Stock Comparison

Last Updated on: May 19, 2025

Key Highlights

  • The Latest Trading Price of Kilitch Drugs (India) Ltd is ₹ 447.1 as of 19 May 11:18.
  • The P/E Ratio of Kilitch Drugs (India) Ltd changed from 147.7 on March 2020 to 42.9 on March 2024 . This represents a CAGR of -21.91% over 5 yearsThe P/E Ratio of Kimia Biosciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Kilitch Drugs (India) Ltd changed from ₹ 125.4 crore on March 2020 to ₹ 626.97 crore on March 2024 . This represents a CAGR of 37.97% over 5 yearsThe Market Cap of Kimia Biosciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Kilitch Drugs (India) Ltd for the Dec '24 is ₹ 57.89 crore as compare to the Sep '24 revenue of ₹ 52.64 crore. This represent the growth of 9.97% The revenue of Kimia Biosciences Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Kilitch Drugs (India) Ltd for the Dec '24 is ₹ 10.46 crore as compare to the Sep '24 ebitda of ₹ 11.26 crore. This represent the decline of -7.1% The ebitda of Kimia Biosciences Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Kilitch Drugs (India) Ltd changed from ₹ 3.06 crore to ₹ 5.61 crore over 7 quarters. This represents a CAGR of 41.39% The net profit of Kimia Biosciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Kilitch Drugs (India) Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Kilitch Drugs (India) Ltd

  • Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe.
  • Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices. The Company is engaged in development, manufacturing and marketing of quality finished dosages.
  • The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.

About Kimia Biosciences Ltd

  • Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
  • The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
  • The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
  • It came out with a public issue in Feb.'95 to part-finance the project.
  • Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking.

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 19 M...

Read more

14 May 2025 11:58

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 F...

Read more

04 Feb 2025 15:55

News

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

05 Nov 2024 13:41

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 2024 15:38

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

02 Aug 2024 17:27

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 27 M...

Read more

20 May 2024 19:21

Kimia Biosciences Ltd News Hub

News

Kimia Biosciences to conduct board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 5 May 20...

Read more

02 May 2025 13:01

News

Kimia Biosciences to convene board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 23 April...

Read more

21 Apr 2025 09:32

News

Kimia Biosciences to hold board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 13 Febru...

Read more

08 Feb 2025 16:02

News

Kimia Biosciences to convene AGM

Kimia Biosciences announced that the Annual General Meeting(AGM) of the company will be he...

Read more

06 Dec 2024 17:04

News

Kimia Biosciences to conduct board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 5 Decemb...

Read more

30 Nov 2024 14:47

News

Kimia Biosciences to discuss results

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

12 Nov 2024 16:44

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kimia Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kilitch Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Kilitch Drugs (India) Ltd and Kimia Biosciences Ltd

Which company has a larger market capitalization, Kilitch Drugs (India) Ltd or Kimia Biosciences Ltd?

Market cap of Kilitch Drugs (India) Ltd is 691 Cr while Market cap of Kimia Biosciences Ltd is 197 Cr

What are the key factors driving the stock performance of Kilitch Drugs (India) Ltd and Kimia Biosciences Ltd?

The stock performance of Kilitch Drugs (India) Ltd and Kimia Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kilitch Drugs (India) Ltd and Kimia Biosciences Ltd?

As of May 19, 2025, the Kilitch Drugs (India) Ltd stock price is INR ₹430.15. On the other hand, Kimia Biosciences Ltd stock price is INR ₹41.69.

How do dividend payouts of Kilitch Drugs (India) Ltd and Kimia Biosciences Ltd compare?

To compare the dividend payouts of Kilitch Drugs (India) Ltd and Kimia Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions